Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun;64(3):165-8.
doi: 10.1007/s13224-014-0541-4. Epub 2014 May 8.

Immunomodulation in recurrent miscarriage

Ashok Kumar  1
Affiliations
Review

Immunomodulation in recurrent miscarriage

Ashok Kumar. J Obstet Gynaecol India. 2014 Jun.

Abstract

There are many etiological factors responsible for recurrent abortions. However, no explanation can be identified in approximately 40-50 % of women with recurrent miscarriage (RM). Several studies demonstrated that successful pregnancy is dependant on shifting of maternal immune response from (proinflammatory) Th1 toward (anti-inflammatory) Th2 phenotypes. It was suggested that unexplained RM might be due to immunologic factors. Recently, there is improved understanding regarding the role of the different immune cells and proteins that are important at each stage of a normal pregnancy. Various immune-based therapies with variable clinical evidences have been reported in women with RM with variable efficacy. Still there is lack of information about the mode of action and possible adverse effects of the treatment and a reliable marker for patient selection for immunopotentiation. Adequately powered placebo-controlled studies are required to study and treat couples with the so-called idiopathic recurrent miscarriage.

Keywords: Immune system; Immunomodulation; Pregnancy; Recurrent pregnancy loss.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Stirrat GM. Recurrent miscarriage: definition and epidemiology. Lancet. 1990;336(673–67):5. - PubMed
    1. Shormila R, Knapp LA. Human reproductive failure I: immunological factors. Hum Reprod Update. 2000;7:113–134. - PubMed
    1. Moff ett-King A. Natural killer cells and pregnancy. Nat Rev Immunol. 2002;2:656–663. doi: 10.1038/nri886. - DOI - PubMed
    1. Raghupathy R, Makhseed M, Azizieh F, Omu A, Gupta M, Farhat R. Cytokine production by maternal lymphocytes during normal human pregnancy and in unexplained recurrent spontaneous abortion. Hum Reprod. 2000;15:713–718. doi: 10.1093/humrep/15.3.713. - DOI - PubMed
    1. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-Shamali E. Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol. 1999;196:122–130. doi: 10.1006/cimm.1999.1532. - DOI - PubMed

LinkOut - more resources